Select your region
UK & Europe
Australia & NZ
Global

GL

Data and AI Solutions

Our commitment to security, safety and responsible use of clinical data for practices and patients.

By utilising clinical data and artificial intelligence tools, we can drive positive outcomes in healthcare safely and securely, together.

For decades, medical professionals across Australia have been using Genie® and Gentu® in their practice. Magentus is also a trusted provider of clinical software for medical oncology, laboratory information management, and radiology across Australia and the UK. To meet modern needs, our software is evolving from storing data to intelligently processing, prompting, summarising, and suggesting. With these advanced capabilities, it’s essential that customers and patients understand how data is used, how AI is applied, and how privacy is protected. Central to this is ensuring clear consent to participate or the ability to opt–out of these data and AI solutions. 

The Magentus Data and Artificial Intelligence Charter

Our Charter lies at the heart of what we do in the field of data, analytics and artificial intelligence. Core to this Charter are the following principles:  

User and patient value are paramount in all decisions related to data and artificial intelligence usage and we prioritise activities that are directly designed to improve patient care and outcomes. 

Via this Trust Centre and otherwise, we maintain clear communication with our customers about how data and artificial intelligence drive improved user experience with our products and provide the health care ecosystem with aggregated insights on population health. 

Security and trust are at the very core of how we operate and constantly evolve. Our information security management system is ISO27001:2022 certified. We implement advanced technical safeguards throughout our data architecture. Privacy controls are embedded in our systems from initial design stages, and we regularly review and enhance our security protocols. 

In instances where large language models are applied to create structured data outputs from unstructured data sources, data is first de-identified before the language models are applied.  

For external data and AI solutions where insights are provided to project sponsors, or in conversations with Government Health Departments, where we may use data-based insights to advocate on our customers’ behalf, data is aggregated to protect the anonymity of practices, health care professionals and their patients. 

Our privacy policy can be viewed here.

We will only ever use data and artificial intelligence for reasons that are aligned to our objective of delivering better healthcare outcomes through world-class technology. Our Chief Medical Officer has oversight of all our data and AI solutions and ensures that we are only using data for this purpose.  A panel of clinical experts and practicing healthcare professionals from a range of specialties advise Magentus on data and artificial intelligence solutions on a regular basis. This advisory panel undertakes careful assessment of proposed uses of data and artificial intelligence to provide a clinical perspective on its appropriate use. 

Where our external data and AI solutions assist a project sponsor in conducting research, we recommend that the project sponsor apply the principles of the National Statement on Ethical Conduct in Human Research (2025) including those related to seeking review by a Human Research Ethics Committee (HREC). We assist our project sponsors on applications to a HREC with respect to the data collection applied within our external data and AI solutions.  

Our data and artificial intelligence practices comply with relevant legal and regulatory requirements. We participate in industry standard-setting initiatives and adhere to the international FHIR framework for healthcare data interoperability.

Magentus data and artificial intelligence solutions

Data and artificial intelligence solutions are categorised in two ways depending on the applicability of the use case to our customers or to other stakeholders:

  • Internal Data and AI Solutions: Services that provide tools and functionality directly to our practices for their own purposes.

  • External Data Solutions: for practices that choose to opt-in to the Magentus Research Program, this includes services that provide pooled, de-identified aggregated insights to third parties for the purposes of optimising health care at a population level.
About Data and AI Solutions

Technology is evolving rapidly, and Magentus as your trusted practice partner wants to make sure you can access innovation, but only when you feel comfortable. 

Magentus offers two distinct types of innovation-driving Data Projects, and we want to be transparent about how each works. Internal Data Projects are built-in functional enhancements to your Genie or Gentu product that require Magentus to access data. These projects, enabled by default, can unlock future features for your practice, such as smarter patient summaries or clinical decision support tools.  

External Data Projects form part of our voluntary Magentus Research Program, whereby data is de-identified and then aggregated to generate insights for research and broader health outcomes improvement. No practice is included in any External Data Project without that practice’s explicit consent.  

By clearly distinguishing Internal vs External Data Projects in this way, Magentus aims to give you full control and confidence over how your data is used. If you have any questions or wish to change your participation status in either type of project, visit our FAQ below or contact [email protected]. 

Internal Data and AI Solutions
Advancements in data and artificial intelligence technologies can assist practitioners in delivering better care to their patients and running their practice more efficiently.

Some examples of internal data and AI solutions (both those that will be available now and those that may become available in the future) are:

    • Dashboards that surface information about a defined patient cohort relating to a particular diagnosis, or guideline of care. Dashboards may be used for clinical audit, continuous professional development or targeted follow-up actions.
    • Clinical decision support that appears as in-product notification where relevant information about an individual patient is delivered at the point of care.
    • Alerts for identifying patients that meet criteria for external programs, such as clinical trials, patient medication access or patient support programs. This may include the ability to seamlessly refer these patients, with their consent, for follow up correspondence to assess further eligibility for recruitment on to these programs.
    • AI-powered processing of clinical interaction data to assist healthcare providers with documentation, correspondence, and revenue cycle management activities.

To provide the data and AI solutions, Magentus may need to access data and other information that is stored within a practice’s Magentus practice management software, or made available during the consultation via ambient listening. As per our security and privacy guidelines, Magentus may also provide such data and information to our trusted ecosystem of technology partners who are engaged to securely host data and provide the language models and infrastructure that make these solutions possible. In certain instances, information that is stored in unstructured data sources like letters and results will be processed through large language models (or similar) for data to be made usable in a structured format. Data and information from a practice will not be used to train the large language models used to structure the data.

The terms of use of the Internal Data and AI solutions are covered under the standard terms of our engagement with you. In certain instances, including those that enable ambient listening within a consultation, further terms will be made available to practices that wish to use those services, and they will need to acknowledge and agree to them when prompted to access the service.

If you would like to opt-out of some or all the internal data and AI solutions, please contact us at [email protected]. Individual practitioners or users of the Magentus software can opt out without opting the whole practice out.

If you are a patient and would like for your information not to be used for some or all the internal data and AI solutions used by your practice/practitioner, please contact your practice/practitioner in the first instance, or contact us directly at [email protected].

Patient Consent

Your practice does not require any additional patient consent for these internal features beyond what a practice would ordinarily be required to obtain to use any software where the software provider accesses data to provide the software.
External Data Solutions

While a practice uses Magentus’ practice management software, the practice will be asked whether it would like to opt-in to the Magentus Research Program. Only the authorised representative within the practice will be able to opt-in to the program on behalf of the practice (note that an authorised person is someone with the authority to enter into contracts and legally bind the practice. E.g. it could be the owner, founder, director, CEO, general manager, or a senior practitioner of the practice, or a partner (if the practice is a partnership), or someone of similar authority).

By opting-in to the Magentus Research Program, deidentified data from the relevant practice will be pooled with deidentified data from other practices that also opt-in and then used to deliver aggregated insights to third party project sponsors.

As is the case for the internal data and AI solutions, in certain instances information that is stored in unstructured data sources like letters and results will need to be processed through large language models (or similar) for data to be made usable in a structured format.

Before information is passed through these models, it is first de-identified or redacted to remove any personal information. Data and information from a practice will not be used to train the relevant model used to structure, transcribe or process the data.

By aggregating the insight before it is made available to project sponsors, the anonymity of a practice’s patients, healthcare practitioners and the practice is maintained.

The types of projects that a practice will be involved in by opting in to the Magentus Research Program include:

  • Improving patient outcomes
  • Population health monitoring and insight that to guides public health decisions
  • Healthcare system improvement
  • Research advancement
  • Insight that guides the development of new therapies or gives better access to new therapies
  • Tools that identify trends and predict future patterns relating to patient care.


Practices that are part of the Magentus Research Program are encouraged to raise any opportunities for projects that they’d like to have considered via [email protected]. This includes opportunities for a practice to benefit from clinical trial patient eligibility checks for clinical trials that may be being run at the practice or in the relevant practice area.

Practices that have opted to be part of a Magentus Research Program can still opt-out at any time by contacting us at [email protected]. The Practice as a whole or individual practitioners, or users of the Magentus software can opt-out, noting that if any individual practitioner or user opts-out, the whole Practice will be opted out.

If you are a patient and would like for your information not to be used for some or all the external data solutions that your practice/practitioner may have opted into, please contact your practice/practitioner in the first instance, or contact us directly at [email protected].

Patient Consent

To ensure that as a practice you have received the patient consents that recognise these Data and AI solutions, we recommend that you obtain your own legal advice. Such advice may include inserting language to the following effect in your patient intake/consent forms or similar:

“I agree that information about me or my consultation may be collected, de-identified and then used to provide me with more informed treatment, or for research projects that the practice may opt to participate in. Such research projects will be limited to the provision of de-identified aggregated information to third party sponsors to support projects that are assessed for ethical implications and public benefit (e.g. population health monitoring, healthcare system improvement). Please speak to your practitioner for further information on any research projects the practice may have opted into and advise your practitioner or the practice if you wish to opt-out of being included in such research projects."

Internal Data and AI Solutions
Internal Data and AI Solutions
Advancements in data and artificial intelligence technologies can assist practitioners in delivering better care to their patients and running their practice more efficiently.

Some examples of internal data and AI solutions (both those that will be available now and those that may become available in the future) are:

    • Dashboards that surface information about a defined patient cohort relating to a particular diagnosis, or guideline of care. Dashboards may be used for clinical audit, continuous professional development or targeted follow-up actions.
    • Clinical decision support that appears as in-product notification where relevant information about an individual patient is delivered at the point of care.
    • Alerts for identifying patients that meet criteria for external programs, such as clinical trials, patient medication access or patient support programs. This may include the ability to seamlessly refer these patients, with their consent, for follow up correspondence to assess further eligibility for recruitment on to these programs.
    • AI-powered processing of clinical interaction data to assist healthcare providers with documentation, correspondence, and revenue cycle management activities.

To provide the data and AI solutions, Magentus may need to access data and other information that is stored within a practice’s Magentus practice management software, or made available during the consultation via ambient listening. As per our security and privacy guidelines, Magentus may also provide such data and information to our trusted ecosystem of technology partners who are engaged to securely host data and provide the language models and infrastructure that make these solutions possible. In certain instances, information that is stored in unstructured data sources like letters and results will be processed through large language models (or similar) for data to be made usable in a structured format. Data and information from a practice will not be used to train the large language models used to structure the data.

The terms of use of the Internal Data and AI solutions are covered under the standard terms of our engagement with you. In certain instances, including those that enable ambient listening within a consultation, further terms will be made available to practices that wish to use those services, and they will need to acknowledge and agree to them when prompted to access the service.

If you would like to opt-out of some or all the internal data and AI solutions, please contact us at [email protected]. Individual practitioners or users of the Magentus software can opt out without opting the whole practice out.

If you are a patient and would like for your information not to be used for some or all the internal data and AI solutions used by your practice/practitioner, please contact your practice/practitioner in the first instance, or contact us directly at [email protected].

Patient Consent

Your practice does not require any additional patient consent for these internal features beyond what a practice would ordinarily be required to obtain to use any software where the software provider accesses data to provide the software.
External Data Solutions
External Data Solutions

While a practice uses Magentus’ practice management software, the practice will be asked whether it would like to opt-in to the Magentus Research Program. Only the authorised representative within the practice will be able to opt-in to the program on behalf of the practice (note that an authorised person is someone with the authority to enter into contracts and legally bind the practice. E.g. it could be the owner, founder, director, CEO, general manager, or a senior practitioner of the practice, or a partner (if the practice is a partnership), or someone of similar authority).

By opting-in to the Magentus Research Program, deidentified data from the relevant practice will be pooled with deidentified data from other practices that also opt-in and then used to deliver aggregated insights to third party project sponsors.

As is the case for the internal data and AI solutions, in certain instances information that is stored in unstructured data sources like letters and results will need to be processed through large language models (or similar) for data to be made usable in a structured format.

Before information is passed through these models, it is first de-identified or redacted to remove any personal information. Data and information from a practice will not be used to train the relevant model used to structure, transcribe or process the data.

By aggregating the insight before it is made available to project sponsors, the anonymity of a practice’s patients, healthcare practitioners and the practice is maintained.

The types of projects that a practice will be involved in by opting in to the Magentus Research Program include:

  • Improving patient outcomes
  • Population health monitoring and insight that to guides public health decisions
  • Healthcare system improvement
  • Research advancement
  • Insight that guides the development of new therapies or gives better access to new therapies
  • Tools that identify trends and predict future patterns relating to patient care.


Practices that are part of the Magentus Research Program are encouraged to raise any opportunities for projects that they’d like to have considered via [email protected]. This includes opportunities for a practice to benefit from clinical trial patient eligibility checks for clinical trials that may be being run at the practice or in the relevant practice area.

Practices that have opted to be part of a Magentus Research Program can still opt-out at any time by contacting us at [email protected]. The Practice as a whole or individual practitioners, or users of the Magentus software can opt-out, noting that if any individual practitioner or user opts-out, the whole Practice will be opted out.

If you are a patient and would like for your information not to be used for some or all the external data solutions that your practice/practitioner may have opted into, please contact your practice/practitioner in the first instance, or contact us directly at [email protected].

Patient Consent

To ensure that as a practice you have received the patient consents that recognise these Data and AI solutions, we recommend that you obtain your own legal advice. Such advice may include inserting language to the following effect in your patient intake/consent forms or similar:

“I agree that information about me or my consultation may be collected, de-identified and then used to provide me with more informed treatment, or for research projects that the practice may opt to participate in. Such research projects will be limited to the provision of de-identified aggregated information to third party sponsors to support projects that are assessed for ethical implications and public benefit (e.g. population health monitoring, healthcare system improvement). Please speak to your practitioner for further information on any research projects the practice may have opted into and advise your practitioner or the practice if you wish to opt-out of being included in such research projects."

FAQs

At Magentus we’re trying to create a future where healthcare networks are optimised for better care, harnessing the full potential of health technology and constant innovation. We believe that data can be responsibly and safely used to improve the lives of patients. By developing a data platform and leveraging the power of AI, we believe we can give practices and healthcare organisations access to deeper insights, so they can provide more efficient and more informed healthcare.

Some internal data and AI solutions like clinical decision support will seamlessly be made available to practices through its Magentus practice management software and will be covered by the software’s master services agreement with us. Other internal data and AI solutions (for instance where ambient scribe is used) will require the Practice to accept additional terms and these will be provided at the point in time where the Practice is attempting to access these solutions. If a practice would like to opt out of any solutions at any time, it can contact [email protected].

Participation in the Magentus Research Program will require the authorised representative of a practice to explicitly opt-in. This can be done via the prompting that will occur within the practice’s Magentus software. When an authorised representative opts-in, all data from the practice that is stored within the practice’s Magentus software will be made available to the program. If you would like to change your participation election, you can email [email protected] at any time.

A practice is responsible for securing the relevant patient consent for Magentus to provide the practice with practice management software inclusive of data and AI solutions. Whilst it is up to the practice to obtain its own legal advice on data and artificial intelligence usage within the practice, we have provided some suggested language for inclusion in a practice’s new patient onboarding forms to ensure the practice’s patients are aware that these types of solutions are being employed in delivering care to them – please refer to the “Patient Consent” section above.

In conversations with your patient around data use, it is relevant to advise them that no personal information is provided into large language models for the purposes of data structuring for data usability purposes and that no data from the practice is used to train these models. Should the practice choose to opt-in to external data and AI solutions, only very de-identified and aggregated information is provided to project sponsors or other third parties.

If a patient would like to opt out of data and AI solutions (whether internal or external), the patient should advise their practice/practitioner, who should in turn advise us of the patient’s election by contacting us at [email protected].

A practice can always change its election with respect to participating in data and AI solutions (whether internal or external) by contacting us at [email protected].

We carefully select who we work with and the projects that we undertake to ensure they align with our values and vision of improving patient outcomes. These may include universities, pharmaceutical companies, medical device companies, research organisations, and government agencies. If there is a project that a practice is interested in undertaking via the Magentus Research Program, please get in touch via [email protected].

We will only ever use data for the goal of improving patient outcomes. Our Chief Medical Officer has oversight of all our data and AI solutions and ensures that we are only using data for these purposes. We have a panel of clinical experts and practicing healthcare professionals from a range of specialties who advise us on our data and AI solutions on a regular basis. This advisory panel undertakes careful assessment of proposed uses of data to provide a clinical perspective on its appropriate use. We will provide updates on future developments, improvements and opportunities over time to keep all practices informed.

Magentus will not directly sell practice data or any patient personal information. However, if a practice chooses to opt-in to the Magentus Research Program as part of our external data solutions, we may use de-identified data to create aggregated insights that are then provided to project sponsors in return for a commercial benefit. Not all projects will involve a commercial benefit, and we may use data as part of the external data solutions to provide insight back to our customers or to government departments and agencies in a way that allows us to advocate on behalf of our customers.

By participating in in the Magentus Research Program a practice will be assisting in the development of more efficient ways of conducting research that make use of pooling routinely collected information across the breadth of Magentus’ practice management user base. Wherever possible, insights that are created from these solutions will be returned to participating practices. Participating practices will be able to put forward projects that they are keen to be part of through their associations and affiliations. At times, practices that are part of the Magentus Research Program may be invited to use tools that utilise data and/or artificial intelligence solutions before they are made available to other customers and will be invited to provide feedback and explore other opportunities for collaboration on new innovation in these areas.

All historical and future data that exists within a practice’s practice management database that is accessible via the Magentus software, has the potential to be included in the projects that we work on. If a practice decides in the future to opt-out of the Magentus Research Program, no data from the point in time that the practice elects to opt-out, will be used in any future project as part of the Magentus Research Program.

Last Updated: December 2025

️×
Select region
UK & Europe
Australia & NZ
Global